NCT03632161View on ClinicalTrials.gov

Para-vertebral Dexmedetomidine and the Incidence of Postoperative Chronic Pain

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

January 23, 2018

Study Completion Date

April 15, 2018

Conditions
Pain, Postoperative
Interventions
DRUG

Dexmedetomidine

isobaric bupivacaine 0.5% (0.3ml/kg) and dexmedetomidine (1 mcg/kg)

DRUG

Bupivacaine

isobaric bupivacaine 0.5% (0.3ml/kg)

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03632161 - Para-vertebral Dexmedetomidine and the Incidence of Postoperative Chronic Pain | Biotech Hunter | Biotech Hunter